Literature DB >> 2844988

Enhancement of class I HLA antigen expression by cytomegalovirus: role in amplification of virus infection.

J E Grundy1, H M Ayles, J A McKeating, R G Butcher, P D Griffiths, L W Poulter.   

Abstract

We have investigated the effect of cytomegalovirus (CMV) infection on the expression of class I HLA antigens on fibroblasts in vitro. Scanning and integrating microdensitometry was used to quantitate the level of cytoplasmic class I antigen expression, and an antibody binding assay was used to quantitate cell surface expression of class I HLA molecules. CMV infection resulted in a significant increase in the level of cytoplasmic and cell surface class I HLA antigen expression of fibroblast monolayers. The maximal effect was seen at 72 hours postinfection and was observed with both the laboratory strain of CMV, strain AD169, and with CMV purified directly from clinical specimens. Part of the increased HLA expression was mediated by interferon released from infected cells; however, an additional direct effect of the virus itself has not been ruled out. Interferon-induced increased expression of class I HLA antigens was accompanied by increased binding of CMV to the cells, consistent with our recent demonstration that class I HLA molecules can function as a cellular receptor for CMV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844988     DOI: 10.1002/jmv.1890250412

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Failure of antiviral therapy in AIDS-associated cytomegalovirus cholangitis.

Authors:  M E van der Ende; A C van Buuren; A C Kroes; F J ten Kate
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

2.  Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus.

Authors:  J E Grundy; K L Downes
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

3.  Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody.

Authors:  J E Grundy; G S Pahal; A N Akbar
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

Review 4.  Modulation of major histocompatibility complex antigen expression by viral infection.

Authors:  C R Rinaldo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

5.  Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells.

Authors:  Y Yamashita; K Shimokata; S Saga; S Mizuno; T Tsurumi; Y Nishiyama
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments.

Authors:  A Bhatia; S Blades; G Cambridge; J C Edwards
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

7.  Double fluorescence analysis of human cytomegalovirus (HCMV) infected human fibroblast cultures by flow cytometry: increase of class I MHC expression on uninfected cells and decrease on infected cells.

Authors:  M Steinmassl; K Hamprecht
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes.

Authors:  A P Warren; D H Ducroq; P J Lehner; L K Borysiewicz
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

Review 9.  Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation.

Authors:  R Ehrlich
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

10.  Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains.

Authors:  T R Jones; L K Hanson; L Sun; J S Slater; R M Stenberg; A E Campbell
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.